Transcripts

CytomX Therapeutics (CTMX) earnings call transcripts

Every CytomX Therapeutics, Inc. earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed Varsetta M as broadening from late-line CRC toward pivotal development, earlier-line combinations, and pan-GI expansion.

    Aug 06, 2026Confident0.86